Antiviral Prophylaxis and Treatment in Haematopoietic Stem Cell Transplant and Immunocompromised children guideline

Published: 21 November 2024

This guideline provides recommendations regarding best practice for Antiviral Prophylaxis and Treatment primarily in children undergoing Haematopoietic Stem Cell Transplantation (HSCT), and can also be applied to management of other immunocompromised children.

Files

Thumbnail of Antiviral Prophylaxis and Treatment in Haematopoietic Stem Cell Transplant and Immunocompromised children guideline
  • Audience Health professionals; Staff
  • FormatDocument
  • Information typeStandards and guidelines
  • LanguageEnglish
  • Last updated21 November 2024

Topics